These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1564124)

  • 1. Dosage regimen design: a pharmacokinetic approach.
    Thompson GA
    J Clin Pharmacol; 1992 Mar; 32(3):210-4. PubMed ID: 1564124
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacokinetics.
    Graham GG; Kennedy M
    Med J Aust; 1979 May; 1(9):383-5. PubMed ID: 470755
    [No Abstract]   [Full Text] [Related]  

  • 3. A unified pharmacokinetic approach to individualized drug dosing.
    Begg EJ; Chin PK
    Br J Clin Pharmacol; 2012 Mar; 73(3):335-9. PubMed ID: 21851378
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basic pharmacokinetics--balance].
    Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2005 May; 125(10):1344-5. PubMed ID: 15909009
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug dosing in renal insufficiency.
    Talbert RL
    J Clin Pharmacol; 1994 Feb; 34(2):99-110. PubMed ID: 8163720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics.
    Bauer LA
    Nurse Pract; 1982 Oct; 7(9):42-3, 46-7, 50. PubMed ID: 7145245
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic aspects of drug therapy in the elderly.
    Greenblatt DJ; Abernethy DR; Shader RI
    Ther Drug Monit; 1986; 8(3):249-55. PubMed ID: 3750364
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dosage of drugs with regard to their distribution volume and biological half-life].
    Dahl SG
    Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1208-11. PubMed ID: 4600750
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics in clinical practice. I. Concepts.
    Gibaldi M; Levy G
    JAMA; 1976 Apr; 235(17):1864-7. PubMed ID: 946488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
    Chen ML
    Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
    [No Abstract]   [Full Text] [Related]  

  • 12. Elimination half-life of drugs: value and limitations.
    Greenblatt DJ
    Annu Rev Med; 1985; 36():421-7. PubMed ID: 3994325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance.
    Ishida K; Kayano Y; Taguchi M; Hashimoto Y
    Biol Pharm Bull; 2007 Nov; 30(11):2159-62. PubMed ID: 17978492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.
    Chiou WL; Gadalla MA; Peng GW
    J Pharmacokinet Biopharm; 1978 Apr; 6(2):135-51. PubMed ID: 671220
    [No Abstract]   [Full Text] [Related]  

  • 15. [Safe drug prescribing for patients with renal failure].
    Tanaka A; Shimizu H; Matsuo S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():58-66. PubMed ID: 18074518
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephro-pharmacology.
    Keller F; Ludwig U; Czock D
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):343. PubMed ID: 16961164
    [No Abstract]   [Full Text] [Related]  

  • 17. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal failure, drug pharmacokinetics and drug action.
    Fabre J; Balant L
    Clin Pharmacokinet; 1976; 1(2):99-120. PubMed ID: 13956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of disposition half-life, clearance, and residence times.
    Mayersohn M
    Curr Protoc Toxicol; 2001 May; Chapter 5():Unit5.3. PubMed ID: 20949436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
    Knights J; Rohatagi S
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.